Physician profile
Andrew Rabenstein
NPI 1841652385
$6,988.37
in general payments reported to CMS, 2019-2025
11 companies · $3,376 in 2025
The $3,376 reported for 2025 was more than what 76% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,357 · 2024: $2,256 · 2025: $3,376.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,889 · Food and Beverage: $2,075 · Education: $1,500 · Consulting Fee: $525.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,888.85 |
| Food and Beverage | $2,074.52 |
| Education | $1,500.00 |
| Consulting Fee | $525.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,199.85 | 2025 | Endurant Iis |
| Atricure, INC. | $1,740.83 | 2023-2025 | Synergy Ablation System, Atricure Cryoice Cryoablation System (Cryo2), Atriclip Laa Exclusion System |
| Intuitive Surgical, INC. | $1,500.00 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $658.68 | 2023-2024 | Imfinzi |
| Edwards Lifesciences Corporation | $345.80 | 2023-2024 | Inspiris Resilia Aortic Valve |
| Abiomed | $246.36 | 2023-2025 | Impella |
| Baxter Healthcare | $139.85 | 2025 | Preveleak |
| Bolton Medical INC | $58.85 | 2025 | Relay Thoracic Stent-Graft With Plus Delivery System |
| W. L. Gore & Associates, INC. | $45.91 | 2025 | Gore Tag Thoracic Branch Endoprosthesis |
| Depuy Synthes Sales INC. | $35.80 | 2024 | Matrixrib |
| Kls-Martin L.P. | $16.44 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Rabenstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.